The Association of Diabetes and Obesity With Prostate Cancer Progression: HCaP-NC

Saira Khan, Jianwen Cai, Matthew E. Nielsen, Melissa A. Troester, James L. Mohler, Elizabeth T.H. Fontham, Laura H. Hendrix, Laura Farnan, Andrew F. Olshan, Jeannette T. Bensen

Research output: Contribution to journalArticle

  • 1 Citations

Abstract

BACKGROUND: The role of race in modifying the association among diabetes, obesity, and prostate cancer (CaP) progression is not well studied. We evaluated diabetes and obesity in association with time to CaP progression in White Americans (Whites) and Black Americans (Blacks). METHODS: Our study sample consisted of 363 White and 284 Black research participants from the Health Care Access and CaP Treatment in North Carolina (HCaP-NC) cohort. The association between self-reported diabetes or obesity and CaP progression (mean follow-up time approximately 5 years) was assessed using Cox proportional hazards modeling, with adjustment for potential confounders. Stratum-specific hazard ratio (HR) estimates for Whites and Blacks were evaluated. RESULTS: Self-reported diabetes was not associated with CaP progression in the cohort as a whole (HR: 0.86, 95%CI: 0.54, 1.35), or among racially defined groups (Whites, HR: 1.03, 95%CI: 0.50, 2.13 or Blacks, HR: 0.77, 95%CI: 0.43, 1.39). Obesity was positively associated with CaP progression among Whites, in models including (HR: 1.79, 95%CI: 1.08, 2.97), and excluding (HR: 1.80, 95%CI: 1.09, 2.96) diabetes as a covariate. No association was observed between obesity and CaP progression in Blacks or the cohort as whole. CONCLUSIONS: Self-reported diabetes was not associated with CaP progression In HCaP-NC. Obesity was associated with CaP progression only among White research participants. Prostate 77:878–887, 2017.

LanguageEnglish (US)
Pages878-887
Number of pages10
JournalProstate
Volume77
Issue number8
DOIs
StatePublished - Jun 1 2017

Fingerprint

Prostatic Neoplasms
Obesity
Delivery of Health Care
Therapeutics
Health Services Research
Proportional Hazards Models
Prostate
Research
hydroquinone

Keywords

  • Black American
  • diabetes
  • HCaP-NC
  • obesity
  • progression
  • prostate cancer

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

The Association of Diabetes and Obesity With Prostate Cancer Progression : HCaP-NC. / Khan, Saira; Cai, Jianwen; Nielsen, Matthew E.; Troester, Melissa A.; Mohler, James L.; Fontham, Elizabeth T.H.; Hendrix, Laura H.; Farnan, Laura; Olshan, Andrew F.; Bensen, Jeannette T.

In: Prostate, Vol. 77, No. 8, 01.06.2017, p. 878-887.

Research output: Contribution to journalArticle

Khan, S, Cai, J, Nielsen, ME, Troester, MA, Mohler, JL, Fontham, ETH, Hendrix, LH, Farnan, L, Olshan, AF & Bensen, JT 2017, 'The Association of Diabetes and Obesity With Prostate Cancer Progression: HCaP-NC' Prostate, vol. 77, no. 8, pp. 878-887. DOI: 10.1002/pros.23342
Khan, Saira ; Cai, Jianwen ; Nielsen, Matthew E. ; Troester, Melissa A. ; Mohler, James L. ; Fontham, Elizabeth T.H. ; Hendrix, Laura H. ; Farnan, Laura ; Olshan, Andrew F. ; Bensen, Jeannette T./ The Association of Diabetes and Obesity With Prostate Cancer Progression : HCaP-NC. In: Prostate. 2017 ; Vol. 77, No. 8. pp. 878-887
@article{c5020788ed404070bb9f3a4a382aa181,
title = "The Association of Diabetes and Obesity With Prostate Cancer Progression: HCaP-NC",
abstract = "BACKGROUND: The role of race in modifying the association among diabetes, obesity, and prostate cancer (CaP) progression is not well studied. We evaluated diabetes and obesity in association with time to CaP progression in White Americans (Whites) and Black Americans (Blacks). METHODS: Our study sample consisted of 363 White and 284 Black research participants from the Health Care Access and CaP Treatment in North Carolina (HCaP-NC) cohort. The association between self-reported diabetes or obesity and CaP progression (mean follow-up time approximately 5 years) was assessed using Cox proportional hazards modeling, with adjustment for potential confounders. Stratum-specific hazard ratio (HR) estimates for Whites and Blacks were evaluated. RESULTS: Self-reported diabetes was not associated with CaP progression in the cohort as a whole (HR: 0.86, 95{\%}CI: 0.54, 1.35), or among racially defined groups (Whites, HR: 1.03, 95{\%}CI: 0.50, 2.13 or Blacks, HR: 0.77, 95{\%}CI: 0.43, 1.39). Obesity was positively associated with CaP progression among Whites, in models including (HR: 1.79, 95{\%}CI: 1.08, 2.97), and excluding (HR: 1.80, 95{\%}CI: 1.09, 2.96) diabetes as a covariate. No association was observed between obesity and CaP progression in Blacks or the cohort as whole. CONCLUSIONS: Self-reported diabetes was not associated with CaP progression In HCaP-NC. Obesity was associated with CaP progression only among White research participants. Prostate 77:878–887, 2017.",
keywords = "Black American, diabetes, HCaP-NC, obesity, progression, prostate cancer",
author = "Saira Khan and Jianwen Cai and Nielsen, {Matthew E.} and Troester, {Melissa A.} and Mohler, {James L.} and Fontham, {Elizabeth T.H.} and Hendrix, {Laura H.} and Laura Farnan and Olshan, {Andrew F.} and Bensen, {Jeannette T.}",
year = "2017",
month = "6",
day = "1",
doi = "10.1002/pros.23342",
language = "English (US)",
volume = "77",
pages = "878--887",
journal = "Prostate",
issn = "0270-4137",
publisher = "Wiley-Liss Inc.",
number = "8",

}

TY - JOUR

T1 - The Association of Diabetes and Obesity With Prostate Cancer Progression

T2 - Prostate

AU - Khan,Saira

AU - Cai,Jianwen

AU - Nielsen,Matthew E.

AU - Troester,Melissa A.

AU - Mohler,James L.

AU - Fontham,Elizabeth T.H.

AU - Hendrix,Laura H.

AU - Farnan,Laura

AU - Olshan,Andrew F.

AU - Bensen,Jeannette T.

PY - 2017/6/1

Y1 - 2017/6/1

N2 - BACKGROUND: The role of race in modifying the association among diabetes, obesity, and prostate cancer (CaP) progression is not well studied. We evaluated diabetes and obesity in association with time to CaP progression in White Americans (Whites) and Black Americans (Blacks). METHODS: Our study sample consisted of 363 White and 284 Black research participants from the Health Care Access and CaP Treatment in North Carolina (HCaP-NC) cohort. The association between self-reported diabetes or obesity and CaP progression (mean follow-up time approximately 5 years) was assessed using Cox proportional hazards modeling, with adjustment for potential confounders. Stratum-specific hazard ratio (HR) estimates for Whites and Blacks were evaluated. RESULTS: Self-reported diabetes was not associated with CaP progression in the cohort as a whole (HR: 0.86, 95%CI: 0.54, 1.35), or among racially defined groups (Whites, HR: 1.03, 95%CI: 0.50, 2.13 or Blacks, HR: 0.77, 95%CI: 0.43, 1.39). Obesity was positively associated with CaP progression among Whites, in models including (HR: 1.79, 95%CI: 1.08, 2.97), and excluding (HR: 1.80, 95%CI: 1.09, 2.96) diabetes as a covariate. No association was observed between obesity and CaP progression in Blacks or the cohort as whole. CONCLUSIONS: Self-reported diabetes was not associated with CaP progression In HCaP-NC. Obesity was associated with CaP progression only among White research participants. Prostate 77:878–887, 2017.

AB - BACKGROUND: The role of race in modifying the association among diabetes, obesity, and prostate cancer (CaP) progression is not well studied. We evaluated diabetes and obesity in association with time to CaP progression in White Americans (Whites) and Black Americans (Blacks). METHODS: Our study sample consisted of 363 White and 284 Black research participants from the Health Care Access and CaP Treatment in North Carolina (HCaP-NC) cohort. The association between self-reported diabetes or obesity and CaP progression (mean follow-up time approximately 5 years) was assessed using Cox proportional hazards modeling, with adjustment for potential confounders. Stratum-specific hazard ratio (HR) estimates for Whites and Blacks were evaluated. RESULTS: Self-reported diabetes was not associated with CaP progression in the cohort as a whole (HR: 0.86, 95%CI: 0.54, 1.35), or among racially defined groups (Whites, HR: 1.03, 95%CI: 0.50, 2.13 or Blacks, HR: 0.77, 95%CI: 0.43, 1.39). Obesity was positively associated with CaP progression among Whites, in models including (HR: 1.79, 95%CI: 1.08, 2.97), and excluding (HR: 1.80, 95%CI: 1.09, 2.96) diabetes as a covariate. No association was observed between obesity and CaP progression in Blacks or the cohort as whole. CONCLUSIONS: Self-reported diabetes was not associated with CaP progression In HCaP-NC. Obesity was associated with CaP progression only among White research participants. Prostate 77:878–887, 2017.

KW - Black American

KW - diabetes

KW - HCaP-NC

KW - obesity

KW - progression

KW - prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=85014494681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014494681&partnerID=8YFLogxK

U2 - 10.1002/pros.23342

DO - 10.1002/pros.23342

M3 - Article

VL - 77

SP - 878

EP - 887

JO - Prostate

JF - Prostate

SN - 0270-4137

IS - 8

ER -